Lam Research (LRCX) balance sheet and financial health

Semiconductor Equipment · NASDAQ · Information Technology

$210.69 -0.07% Close Nov 17, 2026 Live

TrendArc score 79 of 100 · Health 9.8 · Momentum 0.4 · Moat 7.5 · scored Nov 17, 2026 · How the score works

Cash and short-term investments less borrowings, September 27, 2026

$3.7 billion more cash than borrowings

Lam Research held $7.4 billion of cash and short-term investments against $3.7 billion of borrowings on September 27, 2026.

Borrowings to equity

0.27

$3.74B of borrowings on $13.9B of equity, Sep 2026

Return on invested capital

62.4%

latest quarter to September 2026, annualised; the stock card's measure

Cash and borrowings at each fiscal year end

$2.00B$4.00B$6.00B$8.00B2017201820192020202120222023202420252026Cash and short-terminvestments $5.58BBorrowings $3.73B$2.00B$4.00B$6.00B$8.00B20182020202220242026Cash and short-term investments $5.58BBorrowings $3.73B

What stands out

  • Its return on invested capital, as the stock card measures it, had a median of 40.9% over the last five years.

Each sentence is written by a fixed rule from the figures on this page.

What the balance sheet holdsSeptember 27, 2026

Assets $26.4BCash and short-term investments$7.44BReceivables$5.66BInventory$4.55BOther current assets$478MProperty, goodwill and other$8.23BFunded by $26.4BBorrowings$3.74BOther liabilities$8.71BShareholders' equity$13.9BAssets $26.4BCash and short-term investments$7.44BReceivables$5.66BInventory$4.55BOther current assets$478MProperty, goodwill and other$8.23BFunded by $26.4BBorrowings$3.74BOther liabilities$8.71BShareholders' equity$13.9B

"Other liabilities" is total liabilities less borrowings; "Property, goodwill and other" is total assets less the current assets and long-term investments.

Balance sheet, the last 10 fiscal year ends

In billions of US dollars, at each fiscal year end, named by the month it ended; the first column is the newest balance sheet on file. Borrowings are bonds, notes, loans and commercial paper; lease liabilities, operating and finance, are shown apart.
Fiscal year endLatest
Sep 2026
Jun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
Assets
Cash and short-term investments7.45.66.45.85.33.96.07.05.75.26.3
Receivables5.75.33.42.52.84.33.02.11.52.21.7
Inventory4.64.34.34.24.84.02.71.91.51.91.2
Other current assets0.50.40.40.30.30.10.0————
Total current assets18.115.614.512.913.212.311.710.98.69.19.1
Long-term investments0.00.00.00.00.00.00.00.00.00.00.0
Total assets26.423.521.318.718.817.215.914.612.012.512.1
Liabilities and equity
Current liabilities7.35.96.64.34.24.63.53.22.43.23.0
Borrowings3.73.74.55.05.05.05.05.84.52.42.7
Lease liabilities—0.40.30.30.30.30.20.20.00.00.0
Total liabilities12.411.111.510.210.610.99.99.47.35.95.1
Minority interests and other0.00.00.00.00.00.00.00.00.00.10.2
Shareholders' equity13.912.59.98.58.26.36.05.24.76.56.8
Financial health
Cash less borrowings3.71.81.90.90.4-1.11.01.21.22.83.6
Borrowings to equity0.270.300.450.580.600.790.821.120.950.360.39

Interest cover is operating income over interest expense, for full fiscal years. Minority interests and other is total assets less total liabilities and shareholders' equity (calculated by TrendArc). Company filings as standardised by Tiingo; borrowings and lease liabilities told apart with the lines the company files on SEC EDGAR, and a dash where the two cannot be told apart. Rebuilt nightly.

Lam Research against its peers

CompanyCash less borrowingsBorrowings to equityInterest coverReturn on invested capital
Lam ResearchLRCX +$3.70B 0.27 — 62.4%
Applied MaterialsAMAT +$2.69B 0.26 30.8x 32.9%
Axcelis TechnologiesACLS +$472M 0.00 22.2x 13.1%
TeradyneTER +$467M 0.00 95.0x 36.0%
NovaNVMI +$317M 0.56 — 15.6%
CamtekCAMT +$148M 0.84 — 13.8%
KLAKLAC -$982M 0.88 20.7x 50.6%

Each company's newest balance sheet; borrowings leave lease liabilities out; interest cover for its newest fiscal year; return on invested capital is the stock card's measure. A dash where a measure does not apply.

Next

Follow Lam Research with a free account.

A watchlist, price alerts and saved chart layouts. No card needed.

Sign up free

No forecast, no recommendation. This page describes Lam Research from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Nov 17, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.

The TrendArc score, from 0 to 100, combines three pillars measured from published data, Health (business quality over the last twelve months), Momentum (the price against its moving averages, its 52-week high and the market) and Moat (durability over five years), with the share price's long-run trend. It describes the company as it stands today. It is not a forecast or a recommendation.